Do you want to read an article? Please log in or register.
Predictive value of control of COPD for risk of exacerbations: An international, prospective study
COPD
RECOMMENDED
Related content
COMMENTED
Tuberculosis
Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study
Lancet Infect Dis.
Abubakar I, Drobniewski F, Southern J, Sitch AJ, Jackson C, Lipman M, Deeks JJ, Griffiths C, Bothamley G, Lynn W, Burgess H, Mann B, Imran A, Sridhar S, Tsou CY, Nikolayevskyy V, Rees-Roberts M, Whitworth H, Kon OM, Haldar P, Kunst H, Anderson S, Hayward A, Watson JM, Milburn H, Lalvani A; PREDICT Study Team
doi: 10.1016/
RECOMMENDED
COPD
Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study
Respir Res.
Crisafulli E, Ielpo A, Barbeta E, Ceccato A, Huerta A, Gabarrús A, Soler N, Chetta A, Torres A
doi: 10.1186/s12931-018-0951-4.
COPD
Characteristics and risk factors for inconsistency between the risk of exacerbations and the severity of airflow limitation in COPD based on GOLD 2017: A retrospective, cross-sectional study
PLoS One.
Huang WC, Wu MF, Chen HC, Hsu JY
doi: 10.1371/
COPDLung Cancer
Predictive value of a series of inflammatory markers in COPD for lung cancer diagnosis: a case-control study
Respir Res.
Mouronte-Roibás C, Leiro-Fernández V, Ruano-Raviña A, Ramos-Hernández C, Casado-Rey P, Botana-Rial M, García-Rodríguez E, Fernández-Villar A
doi: 10.1186/s12931-019-1155-2.
AsthmaCOPD
β2-Adrenergic genotypes and risk of severe exacerbations in COPD: a prospective cohort study
Thorax.
Ingebrigtsen TS, Vestbo J, Rode L, Marott JL, Lange P, Nordestgaard BG
doi: 10.1136/thoraxjnl-2018-212340.
RECOMMENDED
COPD
COPD clinical control as a predictor of future exacerbations: concept validation in the SPARK study population
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Thorax.
Barrecheguren M, Kostikas K, Mezzi K, Shen S, Alcazar B, Soler-Cataluña JJ, Miravitlles M, Wedzicha JA
doi: 10.1136/thoraxjnl-2018-212752.
COMMENTED
AsthmaCOPD
Airway responsiveness to methacholine and incidence of COPD: an international prospective cohort study
Thorax.
Marcon A, Locatelli F, Keidel D, Beckmeyer-Borowko AB, Cerveri I, Dharmage SC, Fuertes E, Garcia-Aymerich J, Heinrich J, Imboden M, Janson C, Johannessen A, Leynaert B, Pascual Erquicia S, Pesce G, Schaffner E, Svanes C, Urrutia I, Jarvis D, Probst-Hensch NM, Accordini S; Ageing Lungs in European Cohorts (ALEC) study
doi: 10.1136/
AsthmaCOPDPneumonia
Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study
Lancet Respir Med.
Çolak Y, Afzal S, Nordestgaard BG, Vestbo J, Lange P
doi: 10.1016/
RECOMMENDED
COPD
The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Adibi A, Sin DD, Safari A, Johnson KM, Aaron SD, FitzGerald JM, Sadatsafavi M
doi: 10.1016/S2213-2600(19)30397-2.